Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate
Thomas F. Baumert(Inserm), T. Jake Liang(National Institutes of Health), Harry B. Greenberg(Stanford University), John Vergalla, Jujin Satoi(National Institutes of Health), David Herion(National Institutes of Health Clinical Center), Michael M. Thomson(United States Food and Drug Administration), Susumu Ito(Tokyo Women's Medical University), Martin Lechmann(Roche (Switzerland))
Cited by 120
Related Papers
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
|Science Immunology|2020|1.1k
Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection
|Gastroenterology|2011|310